Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

THE INTESTINAL LESIONS IN CYSTIC FIBROSIS OF THE PANCREAS.

THOMAIDIS TS, AREY JB.

J Pediatr. 1963 Sep;63:444-53. No abstract available.

PMID:
14061032
2.

The intestinal Na+/glucose cotransporter.

Wright EM.

Annu Rev Physiol. 1993;55:575-89. Review. No abstract available.

PMID:
8466186
3.

Location of crossovers during gene targeting with insertion and replacement vectors.

Deng C, Thomas KR, Capecchi MR.

Mol Cell Biol. 1993 Apr;13(4):2134-40.

4.

Determinants of mild clinical symptoms in cystic fibrosis patients. Residual chloride secretion measured in rectal biopsies in relation to the genotype.

Veeze HJ, Halley DJ, Bijman J, de Jongste JC, de Jonge HR, Sinaasappel M.

J Clin Invest. 1994 Feb;93(2):461-6.

5.

Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments.

Ramírez-Solis R, Zheng H, Whiting J, Krumlauf R, Bradley A.

Cell. 1993 Apr 23;73(2):279-94.

PMID:
8097432
6.

Long-term survival of the exon 10 insertional cystic fibrosis mutant mouse is a consequence of low level residual wild-type Cftr gene expression.

Dorin JR, Stevenson BJ, Fleming S, Alton EW, Dickinson P, Porteous DJ.

Mamm Genome. 1994 Aug;5(8):465-72.

PMID:
7949729
7.

Ion-transporting activity in the murine colonic epithelium of normal animals and animals with cystic fibrosis.

Cuthbert AW, MacVinish LJ, Hickman ME, Ratcliff R, Colledge WH, Evans MJ.

Pflugers Arch. 1994 Oct;428(5-6):508-15.

PMID:
7838673
8.
9.

High frequency gene targeting using insertional vectors.

Dickinson P, Kimber WL, Kilanowski FM, Stevenson BJ, Porteous DJ, Dorin JR.

Hum Mol Genet. 1993 Aug;2(8):1299-302. No abstract available.

PMID:
7691347
10.

Production of a severe cystic fibrosis mutation in mice by gene targeting.

Ratcliff R, Evans MJ, Cuthbert AW, MacVinish LJ, Foster D, Anderson JR, Colledge WH.

Nat Genet. 1993 May;4(1):35-41.

PMID:
7685652
11.

The molecular biology of cystic fibrosis.

Sferra TJ, Collins FS.

Annu Rev Med. 1993;44:133-44. Review.

PMID:
7682803
12.

The cystic fibrosis transmembrane conductance regulator.

Riordan JR.

Annu Rev Physiol. 1993;55:609-30. Review. No abstract available.

PMID:
7682047
13.

Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens.

Davidson DJ, Dorin JR, McLachlan G, Ranaldi V, Lamb D, Doherty C, Govan J, Porteous DJ.

Nat Genet. 1995 Apr;9(4):351-7.

PMID:
7540910
14.

The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.

Li C, Ramjeesingh M, Reyes E, Jensen T, Chang X, Rommens JM, Bear CE.

Nat Genet. 1993 Apr;3(4):311-6.

PMID:
7526932
16.

Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice.

Clarke LL, Grubb BR, Yankaskas JR, Cotton CU, McKenzie A, Boucher RC.

Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):479-83.

17.

A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus.

O'Neal WK, Hasty P, McCray PB Jr, Casey B, Rivera-Pérez J, Welsh MJ, Beaudet AL, Bradley A.

Hum Mol Genet. 1993 Oct;2(10):1561-9.

PMID:
7505691
18.

Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.

Knowles M, Gatzy J, Boucher R.

N Engl J Med. 1981 Dec 17;305(25):1489-95.

PMID:
7300874
19.

Supplemental Content

Support Center